Cumberland Pharmaceuticals (CPIX) has had the highest return since January 1, 2025 by a US stock in the Pharmaceuticals Industry, returning 98.6%.
| ASSET | % RETURN |
|---|---|
Cumberland Pharmaceuticals (CPIX) | 98.57% |
Intracellular Th (ITCI) | 56.69% |
Trevi Therapeutics (TRVI) | 53.38% |
Sonoma Pharmaceuticals (SNOA) | 42.44% |
Relmada Therapeutics (RLMD) | 42.12% |
Corcept Therapeutics (CORT) | 41.82% |
Verona Pharma PLC ADR (VRNA) | 38.66% |
Amylyx Pharmaceuticals (AMLX) | 38.26% |
Pacira BioSciences (PCRX) | 36.48% |
OptiNose (OPTN) | 35.98% |
Qilian International (BGM) | 28.86% |
Xeris Pharmaceuticals (XERS) | 26.25% |
Royalty Pharma (RPRX) | 26.19% |
ANI Pharmaceuticals (ANIP) | 25.25% |
Axsome Therapeutics (AXSM) | 23.65% |
TherapeuticsMD (TXMD) | 21.41% |
Liquidia Technologies (LQDA) | 18.8% |
Akari Therapeutics (AKTX) | 18.7% |
Novartis AG ADR (NVS) | 18.11% |
Eton Pharmaceuticals (ETON) | 17.84% |
Titan Pharmaceuticals (TTNP) | 16.26% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 14.47% |
Hoth Therapeutics (HOTH) | 13.55% |
CorMedix (CRMD) | 12.27% |
GlaxoSmithKline PLC ADR (GSK) | 11.7% |
